Tevogen Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
6.25
-0.23 (-3.55%)
At close: Aug 7, 2026, 4:00 PM EDT
6.47
+0.22 (3.52%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Tevogen Market Cap
Tevogen has a market cap or net worth of $27.3 million as of August 7, 2026. Its market cap has decreased by -85.20% in one year.
Market Cap
27.30M
Enterprise Value
36.08M
1-Year Change
-85.20%
Ranking
Category
Stock Price
$6.25
ChartMarket Cap Chart
Since January 5, 2022, Tevogen's market cap has decreased from $446.69M to $27.30M, a decrease of -93.89%. That is a compound annual growth rate of -45.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 27.30M | -58.50% |
| Dec 31, 2025 | 65.79M | -63.51% |
| Dec 31, 2024 | 180.30M | 2.42% |
| Dec 29, 2023 | 176.04M | -64.45% |
| Dec 30, 2022 | 495.15M | 10.85% |
| Jan 5, 2022 | 446.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 30.07M |
| CEL-SCI | 30.06M |
| Quince Therapeutics | 29.53M |
| Kyntra Bio | 29.43M |
| Actuate Therapeutics | 26.44M |
| Evaxion | 25.85M |
| ABVC BioPharma | 25.78M |
| IGC Pharma | 25.68M |